Next Article in Journal
Activity of N-Chlorotaurine against Long-Term Biofilms of Bacteria and Yeasts
Next Article in Special Issue
In Vitro Activity of Propolis on Oral Microorganisms and Biofilms
Previous Article in Journal
Identification of Antibiotics in Surface-Groundwater. A Tool towards the Ecopharmacovigilance Approach: A Portuguese Case-Study
Previous Article in Special Issue
Tackling Virulence of Pseudomonas aeruginosa by the Natural Furanone Sotolon
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Antibiotics
Volume 10
Issue 8
10.3390/antibiotics10080890
antibiotics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Elucidation of Phytochemical Content of Cupressus macrocarpa Leaves: In Vitro and In Vivo Antibacterial Effect against Methicillin-Resistant Staphylococcus aureus Clinical Isolates

by
Nashwah G. M. Attallah
1,2,†,
Walaa A. Negm
3,†,
Engy Elekhnawy
4,*,
Elshaymaa I. Elmongy
1,5,*,
Najla Altwaijry
1,
Hala El-Haroun
6,
Thanaa A. El-Masry
7 and
Suzy A. El-Sherbeni
3
1
Pharmaceutical Sciences Department, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh 84428, Saudi Arabia
2
Egyptian Drug Authority (EDA), Giza 8655, Egypt (previously NODCAR)
3
Pharmacognosy Department, Faculty of Pharmacy, Tanta University, Tanta 31111, Egypt
4
Pharmaceutical Microbiology Department, Faculty of Pharmacy, Tanta University, Tanta 31111, Egypt
5
Pharmaceutical Chemistry Department, Faculty of Pharmacy, Helwan University, Helwan 11795, Egypt
6
Histology Department, Faculty of Medicine, Menoufia University, Shibin Al Kawm 32511, Egypt
7
Pharmacology Department, Faculty of Pharmacy, Tanta University, Tanta 31111, Egypt
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Antibiotics 2021, 10(8), 890; https://doi.org/10.3390/antibiotics10080890
Submission received: 16 June 2021 / Revised: 12 July 2021 / Accepted: 15 July 2021 / Published: 22 July 2021
(This article belongs to the Special Issue Plants, Algae and Fungi Extracts: Promising Resources in the Fight against Pathogens)
Browse Figures
Versions Notes

Abstract

:
Methicillin-resistant Staphylococcus aureus (MRSA) is an important human pathogen that causes various infections. The increasing resistance of MRSA to different antibiotics is widely spreading; therefore, plant extracts may be novel therapeutic alternatives. The phytochemical profiling of Cupressus macrocarpa Hartw. ex Gordon leaves in vitro, and in vivo, antimicrobial potential of its extracts against MRSA clinical isolates were explored. A phytochemical tentative identification of 49 compounds was performed in the leaves using LC-ESI-MS/MS; in addition, isolation, and structure elucidation of hesperidin and eriocitrin were achieved for the first time. The diethyl ether extract (DEEL) exhibited the best antibacterial effect with MIC values ranging from 2 to 8 µg/mL, which significantly reduced the growth and efflux activity in 48.78% and 29.26% of isolates, respectively. qRT-PCR showed a significant down expression of norA and norB genes, which significantly affected the bacterial cell morphology and had a non-significant effect on membrane depolarization (using flow cytometry). In a rat model, four groups were wounded and treated with normal saline or DEEL, or infected with MRSA, or infected and treated with DEEL. The regeneration of the epidermis, maturation of granulation tissue, and reduction of inflammatory cell infiltration were observed after treatment with DEEL. Thus, C. macrocarpa leaves may be a promising source for new antimicrobials against MRSA.

1. Introduction

Cupressus macrocarpa Hartw. ex Gordon (Callitropsis macrocarpa) or Monterey cypress (family Cupressaceae) [1,2] is a well-known ornamental tree. It is a gymnosperm plant widely distributed in the United States of America, and warm temperate and subtropical regions in Europe, New Zealand, North Africa, and Asia. It is commonly used as an ornament and for windbreaks [3]. It was used traditionally for decades to treat different diseases and ailments, e.g., whooping cough, as a styptic, to eliminate fluid retention, and rheumatism [4].
C. macrocarpa leaves and branchlets are rich in essential oils [5,6] composed mainly of monoterpenes and traces of sesquiterpenes [7] as well as diterpenes [8], flavonoids, biflavonoids [4,9], and other compounds. The diethyl ether extract is composed mainly of essential oil and non-volatile components, e.g., diterpenes and diterpenoids [10]. It is reported that the essential oils possess a powerful antimicrobial effect [6] and, according to the literature [11], the Essential Oils (Eos) of C. macrocarpa have an antifungal effect against Trichophyton rubrum, a specific dermal fungus. This was the motive to extensively study the antibacterial effect of C. macrocarpa.
Flavonoids are bioactive common components of plants with diverse and remarkable biological activities such as antioxidant or free radical scavenging, anti-inflammatory [12], cardioprotective [13], anticarcinogenic [14], antimicrobial [15], and antiviral [16] activities.
They have a basic C15 phenyl-benzopyrone nucleus, which is biosynthesized from shikimic and acetic or malonic acid precursors. Their structures earn their diversity through differing numbers and positions of substituents including hydroxyl, methoxyl, and glycosyl groups. Glycosides may be of O-, C-, or O- and C-types. Biflavonoids are dimers of flavonoids, usually flavones and flavanones. The interflavonoid linkage is either a C-C bond or occasionally an ether bond. The prevalent C-C attached types are: 6,8″-linked (agathisflavone group), 8,8″-linked (cupressuflavone group), 3′,8″-linked (amentoflavone group) and others. These compounds are restricted in distribution, to be found prevalently in Gymnosperms [17].
Phytochemical investigation of flavonoids, biflavonoids, and other compounds for C. macrocarpa leaves was not previously studied. In this study, chemical profiling was achieved by LC-ESI-MS/MS technique, which supplied us with valuable data about this plant.
The nontargeting small molecule comprehensive analysis of large-scale plant metabolomics that depend on liquid chromatography coupled with electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS) is considered a ubiquitous technique for recognition of different natural products in plants as it can enrich us with information about molecular mass, molecular fragmentation, molecular formula, the relative abundance of different components, as well as determining the type of glycosides and position of substituents.
Staphylococcus aureus is an important human pathogenic bacterium that can cause various infections ranging from superficial skin infections to fatal systemic infections [18]. S. aureus is considered one of the leading causes of nosocomial infections worldwide [19]. The misuse of penicillin has resulted in the emergence of penicillin-resistant S. aureus. In addition, the more problematic bacteria, methicillin-resistant S. aureus (MRSA), have started to spread around the world, causing high rates of morbidity and mortality [20]. This health care problem necessitates the exploring for novel, natural compounds with an antibacterial effect against MRSA isolates. Plants are usually used traditionally for the treatment of certain diseases; thus, many researchers have focused on exploring the antibacterial activity of different plants [21].
This study was conducted to investigate the phytochemical constituents of C. macrocarpa leaves by LC-ESI-MS/MS analysis of the methanol extract of defatted leaves. To the best of our knowledge, there are no reports concerning the antibacterial impact of C. macrocarpa leaf extracts against MRSA isolates. Therefore, an inspection of the potential in vitro and in vivo antibacterial effect of C. macrocarpa leaf extracts against MRSA isolates was carried out.

2. Results

2.1. Results of LC-ESI-MS/MS Analysis of C. Macrocarpa Leaves Methanol Extract

In the current study, the data-independent acquisition-based identification by mass spectral deconvolution using MS-DIAL in LC-ESI-MS/MS analysis (negative mode ESI) of C. macrocarpa leaves methanol extract revealed the tentative identification of 49 compounds of phenolic acids, flavones, flavonols, flavanones, isoflavones, biflavonoids, catechin, stilbene glycosides, and diterpenes. Flavonoids aglycones, O- and C-glycosides were identified. Results are listed in Table 1. The total ion chromatogram (TIC) of methanol extract of C. macrocarpa leaves (negative mode) is presented in Supplementary Materials Figure S1. Whereas, the structures of different compounds are demonstrated in Supplementary Materials Figures S2 and S3.

2.1.1. Characterization of Flavonoids Aglycones

Recognition of different flavonoids aglycons was conducted by an inhouse database to identify luteolin, acacetin, 3, 5, 7-trihydroxy-4′-methoxy flavone, myricetin, quercetin, 3′-methyl quercetin (3′-methoxy-4′,5,7-trihydroxyflavonol), hesperetin, and naringenin through their pseudomolecular ions at m/z 285.038, 283.090, 299.055, 317.055, 301.036, 315.169, 301.118, and 271.064, respectively.

2.1.2. Characterization of Flavones Glycosides and a Biflavone

The common neutral loss of 46 Daltons was observed in MS2 fragmentations of flavones glycoside due to loss of CO2 + H2. Luteolin-7-O-glucoside exhibited [M−H]¯ ions at m/z 447.096. The neutral loss of 162 Daltons of hexose or glucose moiety was detected at m/z 285.040. The pseudo-molecular ions of Luteolin-3′,7-di-O-glucoside at m/z 609.146, with loss of neutral ions of two molecules of hexose or glucose (324 Da), was observed by fragment ion of aglycone at m/z 285.201. Apigenin-7-neohesperidoside (rhoifolin) showed pseudo-molecular ions at m/z 577.156, neutral loss of CO2 (44 Da) indicated at m/z 532.902, and loss of sugar part (308 Da) at m/z 269.104. The pseudo-molecular ions and the aglycone fragment ions of apigenin-7-O-glucoside were detected at m/z 431.092 and 269.035, respectively. The pseudo-molecular ions of baicalein-7-O- glucuronide (baicalin) were noted at m/z 445.169 and the baicalein ions fragment showed at m/z 269.142 due to loss of glucuronide moiety. Cupressuflavone or 8,8″bi-apigenin showed pseudo-molecular ions at m/z 537.021, which were identified according to the reported data [22].

2.1.3. Characterization of Flavonol Glycosides

Quercitrin pseudo-molecular ions demonstrated at m/z 447.180 with loss of rhamnose moiety (146 Da) showing at m/z 301.151 and characteristic fragments at m/z 179.070 and 151.046. The same loss was recorded for quercetin-7-O-rhamnoside. The [M−H]¯ ions were noted at m/z 433.077 for quercetin-3-O-arabinoside with fragment ions at m/z 389.175 for loss of CO2 and m/z 301.037 for loss of pentose moiety (132 Da). The same loss was observed for quercetin-4′-O-glucoside and quercetin-3-O-xyloside with [M−H]¯ ions at m/z 463.119 and 433.080, respectively, as well as common fragments ions at m/z 301 after the loss of hexose or glucose (162 Da) and pentose or xylose (132 Da). The pseudo-molecular ions of quercetin-3,4′-O-β-diglucopyranoside were at m/z 625.071, and loss of di-hexose or di-glucose moieties (324 Da), which was noticed due to the existence of mass fragment ions of quercetin at m/z 301.012. The pseudo-molecular ions and kaempferol ion fragments of kaempferol-3-O-glucuronide were found at m/z 461.127 and 285.103, respectively. Kaempferol-3-O-α-L-arabinoside exerted the [M−H]¯ ions at m/z 417.134 with loss of 132 Daltons of pentose or arabinose fragments at m/z 285.92, the [M−H]¯ ions of kaempferol-3-O-α-L-rhamnoside and myricetin-3-O-rhamnoside (myricitrin) were exhibited at m/z 431.192 and 463.171, respectively. The neutral loss of deoxy hexose or rhamnose was found at m/z 285.213 and 317.103, respectively. Ion fragments of RDA (retro-Diels-Alder) at m/z 125.023 and 119.035 showed in MS2 of kaempferol-3-O-α-L-rhamnoside. Syringetin-3-O-glucoside and syringetin-3-O-galactoside exerted their pseudo-molecular ions at m/z 507.102 and 507.112, respectively, and the loss of neutral ions of hexose (glucose or galactose) moiety (162 Da) was observed at m/z 345.057 and 345.124, respectively. Isorhamnetin-3-O-glucoside showed [M−H]¯ ions at m/z 477.098 with fragment ions of isorhamnetin at m/z 315.041, isorhamnetin-3-O-rutinoside exhibited [M-H]¯ ions at m/z 623.208, neutral loss of CO2 (44 Da) at m/z 579.156, and loss of rutinoside (308 Da) at m/z 315.036.2.1.4. Characterization of flavanone glycosides
The pseudo-molecular ions of naringenin-7-O-glucoside and eriodictyol-7-O-glucoside were observed at m/z 433.115 and 449.102, respectively, as well as their aglycones at m/z 271.053 and 287.032, respectively. The [M−H]¯ ions at m/z 595.286 and the aglycone ion fragments at m/z 287.030 of eriodictyol-7-O-rutinoside were observed, and eriodictyol was formed after neutral loss of rutinoside (308 Da). Hesperidin showed pseudo-molecular ions at m/z 609.144 and fragment ions at m/z 301.027 for hesperetin.

2.1.4. Characterization of Isoflavone

The [M−H]¯ ions at m/z 415.159 were recognized for daidzein-8-C-glucoside with neutral loss of hexose or glucose (162 Da) at m/z 253.165.

2.1.5. Characterization of Phenolic Compounds

The [M−H]¯ ions at m/z 115.081, 173.044, 191.045, 163.039, 289.067, 183.034, 611.117, 181.049, and 359.176 corresponded to maleic, shikimic, quinic, p-coumaric acids, catechin, 3,4-dihydroxy mandelate, neohesperidin dihydrochalcone, syringaldehyde, and rosmarinic acids, respectively. Shikimic and quinic acids showed fragment ions at m/z 155.060 and 173.046 due to neutral loss of water. They also shared common ions at m/z 109 and 93.

2.1.6. Characterization of Other Compounds

Different compounds of 1-O-β-D-glucopyranosyl sinapate, phlorizin, okanin-4′-O-glucoside, E-3,4,5′-trihydroxy-3′-glucopyranosyl-stilbene, and syringaldehyde exhibited m/z at 385.184, 435.084, 449.114, and 405.093, respectively. Diterpenoids as isocupressic acid, acetylisocupressic acid, and agathadiol were established through the reported mass spectrometry data [23].

2.2. Structure Elucidation of Compounds Isolated from C. Macrocarpa Leaves

2.2.1. Structure Identification of Hesperidin

1H NMR (DMSO-d6, 500 MHz) δH: 5.52 (H-2; 1H, dd, J = 12.0, 3.5 Hz), 2.55 (H-3axile; 1H, dd, J = 16.0, 4.0 Hz), 3.78 (H-3equatorial; 1H, dd, J = 16.0, 12.0 Hz), 6. 12 (H-6; 1H, d, J = 2.5 Hz), 6.14 (H-8; 1H, d, J = 2.5 Hz), 6.96 (H-2′; 1H, d, J = 2.0 Hz), 6.91 (H-5′; 1H, d, J = 8.5 Hz), 6.94 (H-6′; 1H, dd, J = 2.0, 8.5 Hz), 3.80 (4′- OMe; 3H, s), 9.12 (3′-OH; 1H, s), 12.01 (5-OH; 1H, s), Glucose moiety: 4.97 (H-1″; 1H, d, J = 7.5 Hz), 3.20-3.60 (H-2″ to H-6″, m), Rhamnose moiety: 4.69 (H-1′′′; 1H, d, J = 3.0 Hz), 3.20-3.60 (H-2‴ to H-5‴, m), 1.09 (6′’’; 3H, d, J = 6.0). 13C NMR(DMSO-d6, 125 MHz)δ: 78.45 (C-2), 40.89 (C-3), 197.48 (C-4), 163.28 (C-5), 96.82 (C-6), 165.57 (C-7), 95.82 (C-8), 162.51 (C-9), 103.56 (C-10), 131.28 (C-1′), 114.61 (C-2′), 146.93 (C-3′), 148.43 (C-4′), 114.61 (C-5′), 118.39 (C-6′), 56.15 (O-Me). Glucose moiety (C-1″ to 6″): 99.91, 74.5, 72.53, 70.13, 76.68, 65.95. Rhamnose moiety (C-1‴ to 6‴): 101.07, 68.84, 70.68, 76.04, 71.28, 18.28. ESI-MS m/z 609.144 [M−H]−.

2.2.2. Structure Elucidation of Eriocitrin

1H NMR (DMSO-d6, 500 MHz) δH: 5.21 (H-2; 1H, dd, J = 12.5, 3.5 Hz), 2.88 (H-3axile; 1H, dd, J = 17.0, 3.5 Hz), 3.09 (H-3equatorial; 1H, dd, J = 17.0, 12.5 Hz), 6. 09 (H-6; 1H, d, J = 2.5 Hz), 6.11 (H-8; 1H, d, J = 2.5 Hz), 6.92 (H-2′; 1H, d, J = 1.5 Hz), 6.60 (H-5′; 1H, d, J = 8.5 Hz), 6.89 (H-6′; 1H, dd, J = 1.5, 8.5 Hz), Glucose moiety: 4.94 (H-1″; 1H, d, J = 7.5 Hz), 3.35-4.25 (H-2″ to H-6″, m), Rhamnose moiety: 4.88 (H-1‴; 1H, d, J = 3.0 Hz), 3.35-4.25 (H-2‴ to H-5‴, m), 1.11 (6‴; 3H, d, J = 6.0). 13C NMR (DMSO-d6, 125 MHz) δ: 80.9 (C-2), 44.89 (C-3), 197.23 (C-4), 163.14 (C-5), 98.12 (C-6), 165.27 (C-7), 96.88 (C-8), 162.59 (C-9), 104.16 (C-10), 130.98 (C-1′), 112.11 (C-2′), 146.53 (C-3′), 148.13 (C-4′), 114.32 (C-5′), 118.13 (C-6′). Glucose moiety (C-1″ to 6″): 101.12, 74.90, 73.09, 71.70, 77.11, 66.80. Rhamnose moiety (C-1‴ to 6‴): 102.11, 70.32, 72.08, 76.81, 72.40, 18.01. ESI-MS m/z 595.286 [M−H]−. Figure 1 represents structures of hesperidin and eriocitrin.

2.3. Results of In Vitro Antibacterial Activity of C. Macrocarpa Leaves Extracts

The total methanol extract (TMEL), diethyl ether extract of leaves (DEEL), and methanol extract of defatted leaves (MEDL) exhibited antibacterial effects on the tested MRSA isolates using the agar well-diffusion method. Their minimum inhibitory concentration (MIC) values were detected using the broth microdilution method. The MIC values for the DEEL of C. macrocarpa ranged from 2 to 8 µg/mL (the most potent). However, the MIC values for MEDL and TMEL ranged from 256 to 1024 µg/mL and 1024 to 2048 µg/mL, respectively. The MIC values for the positive control (vancomycin) ranged from 0.5 to 4 µg/mL.

2.3.1. Growth Curve Assay

To determine the effect of DEEL on the growth of MRSA, the growth curves of the tested isolates were analyzed before and after treatment. A significant reduction of 48.78% in the growth of the tested isolates was observed. A representative example is shown in Figure 2.

2.3.2. Efflux Assay

The efflux pump activity is an important mechanism for antibiotic resistance. Herein, the efflux activity of MRSA isolates was determined by evaluating the ability of each isolate to pump out ethidium bromide (EtBr) out of the bacterial cell. The efflux activity of the isolates was categorized into negative, intermediate, and positive using the EtBr cartwheel method. As shown in Table 2, out of 41 MRSA isolates, 12 (29.26%) isolates showed a decrease in their efflux pump activity after treatment with DEEL (i.e., their efflux pump activity was converted from positive to intermediate or negative).

2.3.3. Quantitative RT-PCR

Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was utilized to study the effect of DEEL on the efflux activity of MRSA isolates (n = 12), which exhibited a decrease in their efflux activity by the cartwheel method. The transcriptional levels of the tested efflux pump genes norA and norB were remarkably decreased after treatment, with mean values of fold changes ranging from 0.1 to 0.45 (in 66.66% of clinical isolates) and from 0.08 to 0.39 (in 50% of clinical isolates), respectively, as shown in Figure 3. The expression level of the norC gene showed nonsignificant fold change after treatment.

2.3.4. Membrane Depolarization Assay

Membrane depolarization was measured before and after treatment with DEEL using DiBAC4(3), which is a fluorescent indicator dye that can enter the cells when depolarized; thus, membrane depolarization can be studied by recording the fluorescence of this dye using a flow cytometer. We observed nonsignificant change in membrane depolarization after treatment. A representative example is shown in Figure 4.

2.3.5. Examination of Bacterial Cell Morphology by Scanning Electron Microscope (SEM)

Examination of the cell morphology of MRSA isolates by SEM was carried out to study the ultrastructural changes that occurred after treatment with DEEL. By comparing the treated cells with the untreated ones, we observed that the treated cells were shrinking and there were some degradations of the cell walls, as shown in Figure 5.

2.3.6. Cytotoxicity Assay

The cytotoxic effect of C. macrocarpa DEEL in a human skin fibroblast (HSF) cell line was determined using SRB (Sulforhodamine B) assay [24]. The results revealed that IC50 of C. macrocarpa DEEL against HSF cell line was 21.3 ± 3.41 µg/mL in comparison with doxorubicin as a positive control (IC50 = 4.36 ± 0.52 µg/mL).

2.4. In Vivo Antibacterial Activity Testing

2.4.1. Wound Closure Percentage (%)

The in vitro antibacterial activity of DEEL was the most potent in comparison with MEDL and TMEL; thus, the antibacterial activity of DEEL was tested in vivo. When DEEL was used to treat wounds, the percentage of wound contraction was significantly higher than in the control group. In addition, when compared to the MRSA-infected group, the infected group treated with DEEL showed a significant increase in wound contraction (Table 3). A significant reduction in the size of the injured area indicated rapid recovery. Figure 6 demonstrates the percentage of the wound area contraction (wound contraction %), collected on days 7 and 14.

2.4.2. Histological Results (H&E)

By day 7, the control group revealed extensive epidermal loss with dermal and epidermal separation occurring on the wound surface. There were inflammatory cells with few fibroblast cells, congested blood vessels, and minimal epidermal growth (Figure 7a). There was epidermal layer regeneration with the less cellular inflammatory response after 14 days, formation of granulation tissue with many cells and some fibers, and moderate collagen deposition (Figure 8a). The group treated with DEEL showed reduced cellular infiltration and regeneration of thin epidermis. Some immature collagen fibers were seen in the dermis after 7 days (Figure 7b). Rats exhibited an incomplete epidermal layer after 14 days. Also, the granulation tissue had newly generated capillaries and higher levels of fibroblast proliferation (Figure 8b). MRSA-treated wound sections after 7 days showed enhanced inflammatory cellular infiltration with necrotic tissue (Figure 7c). By day 14, the granulation tissue was poorly structured, with abundant inflammatory cells, few fibers, and minimal re-epithelialization (Figure 8c).
After 7 days of DEEL treatment for MRSA-infected wounds, incomplete re-epithelization with decreased inflammatory cell aggregation was discovered (Figure 7d). There was an incomplete thin regenerated epidermis after 14 days (Figure 8d).

2.4.3. Mallory Trichrome Stain

Masson’s trichrome sections of the 7-day control group revealed several distributed collagen fibers aligned in various directions (Figure 9a), while the 14-day wound showed moderate collagen fibers accumulating parallel to the epidermis (Figure 10a). In the C. macrocarpa DEEL-treated group, collagen fibers were seen dispersed in numerous orientations (Figure 9b). When compared to the untreated group, there was a considerable increase in thick collagen fibers parallel to the epidermis after 14 days (Figure 10b). In the MRSA-infected group, tiny immature collagen strands were seen in the dermis (Figure 9c). There were scattering irregular collagen fibers after 14 days (Figure 10c). Collagen fibers were found to be thin and uneven after 7 days (Figure 9d) and moderately parallel to the epidermis after 14 days in the infected group treated with DEEL (Figure 10d), which was significantly higher than in the MRSA group (Table 3, Figure 11).

3. Discussion

LC-ESI-MS/MS is considered a powerful tool to analyze different plant extracts to reveal their phytochemical content based on their molecular mass and mass fragmentation pattern. The analysis of methanol extract of defatted leaves of C. macrocarpa exhibited a tentative identification of 49 compounds of flavones, flavonols, 3′, 4′, 5′- trihydroxy flavonols, methoxylated flavonols, flavanones, and their glycosides. Other compounds recognized include: isoflavone e.g., daidzein-8-C-glucoside; biflavonoid e.g., cupressuflavone; labdane diterpenoids e.g., isocupressic acid, acetyl isocupressic acid, and agathadiol; phenolic compounds e.g., shikimic, maleic, quinic acids as well as syringaldehyde, catechin, neohesperidin dihydrochalcone, okanin-4′-O-glucoside, rosmarinic acid, phlorizin; and stilbenes e.g., E-3,4,5′-trihydroxy-3′-glucopyranosyl-stilbene.
The 1H-NMR spectrum of the first compound displayed the characteristic signals of a flavanone structure represented by signals at δH: 2.55 (1H, dd, J = 16.0, 4.0 Hz), 3.78 (1H, dd, J = 16.0, 12.0 Hz) for C-3 protons and δH 5.52 (1H, dd, J = 12.0, 3.5 Hz) for H-2. Signals for meta-coupled protons at δ 6.12 and 6.14 (J = 2.5 Hz) are ascribed to H-6 and H-8. An ABX system was displayed by signals resonating at δ 6.96 (d, J = 2.0 Hz) for H-2′, 6.91 (d, J = 8.5 Hz) for H-5″, and 6.94 (dd, J = 2.0, 8.5 Hz) for H-6″. A methoxy group at C-4′ was compatible with a single signal at δ 3.80 integrated for three protons. Sugar protons ranged from 3.20 to 3.60 ppm (m), while signals for two anomeric protons resonating at δ 4.97 (d, J = 7.5 Hz) and 4.69 (d, J = 3.0 Hz) suggested the presence of β-D-glucose and α-L-rhamnose. The 1H-NMR established the presence of two hydroxyls, resonating at δ 9.12, 12.01 for OH at C-3ʹ and C-5, respectively.
The 13C-NMR spectra revealed the presence of flavanone glycoside by signals resonating at δC 78.45 and 40.89, which could be ascribed to C- 2 and C-3, respectively. Glucose carbons resonated at δ 99.91, 74.5, 72.53, 70.13, 76.68, and 65.95, while rhamnose carbons (1‴ to 5‴) resonated at δ 101.07, 68.84, 70.68, 76.04, and 71.28, as well as C-6′’’ at δ 18.28. The ESI/MS presented ions at m/z 609.144 [M−H]− for C28H34 O15, which is in agreement with the determined structure as hesperidin [25,26]. This is the first report for isolation of hesperidin from C. macrocarpa leaves.
The 1H-NMR spectrum of the second compound established the characteristic signals for the flavanone structure as represented by signals at δH 2.88 (1H, dd, J = 17.0, 3.5 Hz) and 3.09 ppm (1H, dd, J = 17.0, 12.5 Hz) for the two geminal C-3 protons beside the signal at δ 5.21 (1H, dd, J = 12.5, 3.5) for H-2. Signals for meta-coupled protons at δ 6.09 and 6.11 (J = 2.5 Hz) were consistent with H-6 and H-8 assignment, respectively. Signals at δ 6.92 (d, J = 1.5 Hz) for H-2′, 6.89 (dd, J = 1.5, 8.5 Hz) for H-6′, and 6.60 (d, J = 8.5 Hz) for H-5′ displayed an ABX system. Multiple signals for sugar protons resonated from δ 3.35 to 4.25. Signals resonating at δ 4.88 (d, J = 3.0 Hz) and 4.94 (d, J = 7.5 Hz) suggested the presence of α-L-rhamnose and β-D-glucose. The 13C-NMR data revealed the presence of flavanone glycoside. Signals resonating at δC 80.9 and 44.9 could be ascribed to C-2 and C-3, respectively. Glucose carbons resonated at δ 101.12, 74.90, 73.09, 71.70, 77.11, and 66.80, while rhamnose carbons resonated at δ 102.11, 70.32, 72.08, 76.81, 72.40, and 18.01. The ESI/MS of the compound showed ions at m/z 595.286 [M−H]− for C27H32O15, which is in concordance with the determined structure. All spectral data of this compound are consistent with those reported for eriodictioside or eriodictyol- 7-O-rutinoside (eriocitrin) [27,28]. This is the first time reporting the isolation of eriodictioside from C. macrocarpa leaves.
The global spread of multi-drug resistance among pathogenic bacteria has stimulated enormous interest in research for novel antimicrobial agents from plants [29]. In the current study, we observed that the diethyl ether extract of C. macrocarpa leaves showed higher antibacterial activity against MRSA isolates than the methanol extract of defatted leaves and total methanol extract.
The diethyl ether extract was previously investigated phytochemically by GC/MS analysis, which unveiled its phytochemical profile [10]. The major active constituents found in this fraction were abietane diterpenes derivatives, e.g., ferruginol, 13-methyl-13-vinyl-podocarp-7-en-3-one- and 13-isopropyl-podocarpa-6, and 13-diene, as well as monoterpenes which constitute the essential oil part of the diethyl ether extract, e.g., γ-terpinene, α-phellandrene, α-terpinene, camphor, limonene, trans-ocimene, camphene, citronellol, and citronellyl butyrate. [10] Abietane diterpenoids have exerted valuable bioactivity against bacteria and fungias; they were reported to be effective against Mycobacterium tuberculosis and Staphylococcus aureus, including methicillin-resistant (MRSA) strains and biofilm infection of S. aureus [30]. Ferruginol is an aromatic abietane and was reported to exert significant antibacterial effects against Bacillus subtilis, Staphylococcus aureus, and Streptococcus durans [31]. The active constituents in the essential oil of leaves and branchlets exhibited antimicrobial effects e.g., γ-terpinene [32], α-phellandrene [33], α-terpinene [34], camphor, and limonene [35].
The bacterial growth curve has been commonly used to evaluate the effect of antibacterial agents over a given time (usually 24 hrs) [36]. A significant reduction in the growth of 48.78% of the tested isolates was observed after treatment with DEEL. This may indicate that the antibacterial activity of this extract was associated with a variety of physiological factors in the bacterial cell [37], which needs further studies to explore the potential impact of the extract on different cellular events.
Efflux pumps are proteins located in the bacterial cell membrane. Their function is to transfer toxins out of the cell; thus, they confer cellular protection from many toxins. Efflux pumps are considered the main mechanism of resistance to many antibiotics [38]. We observed that 29.26% of MRSA isolates exhibited a decrease in efflux pump activity after treatment with DEEL. S. aureus expresses many efflux pumps that help confer antibiotic resistance. The most common efflux pumps of S. aureus are encoded by norA, norB, and norC [39]. For further explanation of the impact of DEEL on the efflux activity of the twelve MRSA isolates that exhibited a decrease in the efflux pump activity by the EtBr cartwheel method, qRT-PCR was used. We observed that 66.66% (8 out of 12 isolates) and 50% (6 out of 12 isolates) showed a significant down expression of norA and norB genes, respectively, after treatment. A nonsignificant change in the expression level of the norC gene was observed after treatment. Many researchers have focused on the detection of efflux pump inhibitors from plant sources [38,40,41,42]. Such efflux inhibitors from a natural source can be used to decrease antibiotic resistance among pathogenic bacteria [38].
The bacterial cell membrane is a major target for many new antibacterial compounds and dissipation of the bacterial cell membrane potential may be the sole mechanism of action, or it can contribute to the potency of the studied antibacterial compound [43]. Thus, we examined the membrane depolarization in MRSA isolates before and after treatment with DEEL. A nonsignificant change in membrane depolarization after treatment was observed.
Scanning electron microscopy is commonly used in microbiological research to study the ultrastructural changes that occur in the morphology of bacterial cells after treatment with antimicrobial agents [44]. Therefore, SEM was utilized in the current study as it can produce images for the external cell morphology and surface characteristics with higher resolution compared to the light microscope. We observed that the bacterial cells after treatment with DEEL shrunk with degradation to the cell walls.
Wound healing is a vital biological process that happens when a variety of cell types and their products interact synergistically [45]. Bacterial infection, however, can inhibit and impede natural wound healing. S. aureus is a dangerous bacterium that can cause wound infection [46]. From the in vitro antibacterial study, it was found that diethyl ether of C. macrocarpa leaves exhibited the best activity; as a result, we investigated its efficacy on a rat model with an MRSA-infected cutaneous wound.
According to a histological examination, 7 days of untreated wounds showed cellular infiltration with thin collagen fibers. After 14 days, there was a reduction in inflammatory cells, thick collagen deposition, and partial re-epithelialization. Our findings were consistent with those of reported data [47].
Our in vivo study results demonstrated that treatment of DEEL of C. macrocarpa was highly significant against cutaneous wound infection in a rat model. It significantly improved wound contracture and healing. Furthermore, it appeared to improve healing by regenerating the epidermis, maturing granulation tissue, and reducing inflammatory cell infiltration associated with collagen fibers deposition when compared to with the MRSA-infected group. These findings were consistent with those that showed that C. macrocarpa leaves inhibited the production of proinflammatory cytokines such as PGE2, TNF-a, IL-1b, and IL-6, hence preventing chronic inflammation and enhancing wound healing [9]. The histopathology finding was also consistent with previous findings by Saad et al. in 2017 [5].
MRSA-infected wounds were shown to have an abundance of inflammatory cells, few collagen fibers, little re-epithelialization, and inadequate granulation tissue, as well as a significant reduction in wound contracture as compared with untreated wounds. According to researchers, S. aureus infection causes cutaneous collagen breakdown, which leads to impaired granulation tissue and, as a result, delayed wound healing [48].
The cell viability SRB assay of DEEL against HSF normal cell line was performed. IC50 of DEEL was 21.3 ± 3.41 µg/mL in comparison with doxorubicin (IC50 = 4.36 ± 0.52 µg/mL) as a positive control.
Finally, our results provided light on the reusing of C. macrocarpa as an efficient and novel topical therapy to treat MRSA. The current study laid the groundwork for future clinical trials as an antibacterial drug to treat skin infections caused by pathogenic MRSA isolates.

4. Materials and Methods

4.1. Plant Material

Cupressus macrocarpa leaves with branchlets were collected and dried at room temperature in May 2017 from a nursery at Shebin El-Kom, El-Menoufia Governorate. The plant was recognized by Prof. Mohammed Ibrahim Fotoh, Professor of Ornamental Horticulture and Landscape Design. A voucher sample (PG00411) was deposited at Herbarium of the Department of Pharmacognosy, Faculty of Pharmacy, Tanta University. The different extracts were carried out by the cold maceration method. The dried leaves with branchlets (2 kg) of C. macrocarpa were extracted first with 4 L of petroleum ether for 3 days, three times (4 L × 3 times), and then with 5 L of 95% methanol three times (5 L × 3 times) for 3 days each. Both extracts were evaporated under reduced pressure. The yield was 7.5% and 6.2% for petroleum ether and methanol extracts, respectively.

4.2. Method of Isolation of Flavonoids

The dried methanol extract was suspended in a mixture of methanol and water (2:1). The formed suspension was successively extracted with dichloromethane, ethyl acetate, and n-butanol. Extracts of methylene chloride, ethyl acetate, and n-butanol were completely evaporated under a vacuum at 40 °C to obtain a dry residue of each solvent. Ethyl acetate (4 g) was applied to a silica gel column chromatography (160 g, ϕ 5 × 30 cm), and fractions of 50 mL volume were collected. Elution was undertaken with a successive gradient of CH2Cl2–MeOH mixtures of increasing polarities. The CH2Cl2–MeOH (85:15) eluates, A21 (325 mg) and A23 (245 mg), were chromatographed to column chromatography using silica gel (20 g, ϕ 2 × 15 cm). The collected fractions were 15 mL each, which were eluted successively with an increasing gradient of the polarity of CH2Cl2/MeOH mixture. Subfraction B19 eluted from A21 sub-column at (90:10) of CH2Cl2: methanol was purified on Sephadex LH-20 (15 g, ϕ, 2 × 12 cm) with MeOH to afford the first compound (10 mg). Subfraction C15 eluted from A23 sub-column at (88:12) of CH2Cl2: methanol was applied to isocratic CC (10 g, ϕ, 1.2 × 10 cm) on silica gel with CHCl3: MeOH (95:5) to give a yellowish residue; this residue was subjected to Sephadex LH-20 (15 g, ϕ, 2 × 10 cm) with MeOH to give the second compound (8 mg). Structure determination was undertaken by A JEOL ECA-500 II NMR spectrometer, which was used to record NMR spectra. NMR samples were analyzed at 500 MHz for 1H and 125 MHz for 13C. Samples were dissolved in DMSO-d6.

4.3. LC-ESI-MS/MS Analysis of C. Macrocarpa Leaves Extract

4.3.1. Preparation of Plant Sample

A total of 100 g of dried leaves powder was defatted by maceration in petroleum ether at room temperature. After complete exhaustion, methanol was added to the powder, and after extraction, methanol was evaporated under a vacuum at 40 °C. A weighed portion of the residue (50 mg) was reconstituted in a 1 mL solution of deionized water, methanol, and acetonitrile (50: 25: 25). The dissolved sample was vortexed for 2 min, ultra-sonicated for 10 min, and centrifuged for another 10 min at 1000 rpm. Dilution was carried out with the reconstitution solvent to inject 10 µL of the sample solution at a concentration of 1 µg/µL.

4.3.2. LC-ESI-MS/MS Method

Compounds in the crude extracts were identified by Proteomics and Metabolomics Unit, Children’s Cancer Hospital (57357), Basic Research Department, Cairo, Egypt. The crude extracts were reconstituted in DI-Water, methanol, and acetonitrile (50:25:25) and analyzed by LC-ESI-MS/MS using ExionLCTM AD UPLC, coupled with TripleTOF 5600+ Time-of-Flight Tandem Mass Spectrometer (AB SCIEX). The injection concentration was 1 μg/mL and volume 10 μL. The column used was the XSelect HSS T3 XP column (Waters, 2.1 mm × 150 mm) at 40 °C. The flow rate was 300 µL/min of the mixture of 1% methanol in 5 mM ammonium formate buffer (pH 8) (A) and acetonitrile (B). Gradient elution was used as the following: isocratic elution with 90% of solvent A and 10% of acetonitrile for 1 min, gradient elution with 90 to 10% solvent A and 10% to 90% of acetonitrile for 20 min, 90% of acetonitrile for 4 min, and then returned to the initial condition (10% of acetonitrile) for 3 min. Mass spectra were acquired under negative-ion mode in an information-dependent mode with an automatic switch between a full scan (50–1000 m/z) and up to 15 information-dependent MS/MS scans. The intensity threshold to trigger an MS/MS scan was set to 104 ppm. The MS1 and MS2 tolerance values were 0.01 and 0.05 mass units, respectively. The maximum ion monitoring time was 3000 ms. The ion spray voltage was set to 4500 V, the turbo spray temperature 500 °C, nebulizer gas 45 psi, heater gas 45 psi, and declustering potential 80 V, and normalized collision energy 35 V. The dynamic exclusion was applied using a setting of 10 seconds. Raw data files were loaded into MS-DIAL 3.52 (http://prime.psc.riken.jp/) [49] for data-independent MS/MS deconvolution. Compounds were identified with > 70% probability using a MS1 and MS2 tolerance of 0.2 mass unit to be accepted as positive identifications. PeakView was used for feature or peaks extraction from total ion chromatogram (TIC). Based on that, the features should have a signal-to-noise ratio greater than 5 (non-targeted analysis) as well as features intensities of the sample-to-blank ratio as greater than 3.

4.4. Materials and Methods of Antibacterial Study of C. Macrocarpa Leaves Extracts

4.4.1. Bacterial Isolates and Chemicals

A total of 41 MRSA isolates were collected from clinical samples from different departments of Tanta University Hospital. The clinical samples were originally taken from patients for proper diagnosis and treatment, thus ethical approval was not required. The bacterial isolates were viewed microscopically and were identified by standard biochemical tests (MacFaddin, 1976). MRSA isolates were detected phenotypically, using the cefoxitin disk diffusion (30 μg) method [50] and genotypically, using PCR for detection of the mecA gene [51]. Staphylococcus aureus (ATCC 29231) was used as a reference strain.

4.4.2. In vitro Antibacterial Activity Testing

Three different portions of 100 g of leaves and branchlets dried powder, were macerated at room temperature. The first portion was macerated in diethyl ethyl ether (DEEL), the second portion in light petroleum ether tell exhaustion (defatted leaves) then methanol (MEDL), and the third portion in methanol (TMEL) only. Each extract was evaporated under a vacuum to obtain three different residues. The in vitro antibacterial activity of the obtained residues was carried out by agar well diffusion method [52]. Approximately 100 µL of each bacterial suspension was distributed on the surface of plates containing Muller-Hilton agar. Then, five wells were punched off using a cork-borer and each well was filled with 100 μL (1024 µg/mL) of each of the following: DEEL, MEDL, and TMEL (reconstituted in DMSO). The plates were incubated at 37 °C for 24 h using DMSO as a negative control and vancomycin (30 μg/mL) as a positive control.

Determination of MICs

The MIC values were determined for DEEL, MEDL, and TMEL by broth microdilution method using DMSO for dilutions [50]. A well containing a bacterial suspension without the extract (a positive control) and another well containing broth without any bacteria (a negative control) were incorporated in each microtitration plate. The MIC values of the extracts were identified for each bacterial isolate as the lowest extract concentration, which showed complete inhibition of bacterial growth (i.e., absence of turbidity). The subsequent tests (in vitro and in vivo) were accomplished before and after treatment of MRSA isolates with sub-inhibitory concentrations (i.e., 0.5 MIC values ranged from 1 to 4 µg/mL) of DEEL (the most potent).

Growth Curve Assay

This assay was conducted to assess the impact of DEEL on the growth of MRSA (at 0.5 MIC values ranging from 1 to 4 µg/mL) [53]. The optical density (OD) of MRSA (before and after treatment) was measured at 620 nm using 1800 UV–Vis spectrophotometer (SHIMADZU, Kyoto, Japan) at time intervals of 0, 2, 4, 6, 8, and 24 h. The growth curves were constructed by plotting log OD620 versus the sampling time (h).

Efflux Assay

This assay was conducted before and after treatment with DEEL (at 0.5 MIC values ranging from 1 to 4 µg/mL), using the EtBr cartwheel method [39,54], and the reference strain was used as a negative control. Each bacterial suspension was swabbed as redial lines onto tryptic soy agar (TSA) plates supplied with concentrations of EtBr ranging from 0.5 to 2.5 mg/L, and they were incubated for 16 hrs at 37 °C. The minimum concentration of EtBr resulted in the production of fluorescence by the bacterial isolates and was recorded using a UV-Vis transilluminator (SHIMADZU, Kyoto, Japan). MRSA isolates were classified based on the detected minimum concentration of EtBr. Isolates emitting fluorescence at 0.5 mg/L EtBr were considered to have negative efflux activity; isolates emitting fluorescence at 1–2.0 mg/L EtBr were considered to have intermediate efflux activity, and isolates emitting fluorescence at 2.5 mg/L EtBr were considered to have positive efflux activity.

QRT-PCR

The expression levels of the efflux pump genes (norA, norB, and norC) [55] were detected after treatment with DEEL using qRT-PCR. Briefly, after centrifugation of the overnight cultures of MRSA isolates (with and without treatment), the pellets were immediately utilized for total RNA extraction using the Purelink® RNA Mini Kit (Thermo SCIENTIFIC, Waltham, USA) as described by the manufacturer. The purified RNA was rapidly retrotranscribed into cDNA using a power cDNA synthesis kit (iNtRON Biotechnology, Korea) as recommended by the manufacturer. qRT-PCR was accomplished using the Rotor-Gene Q 5plex machine (Qiagen, Hilden, Germany). The qRT-PCR was conducted to calculate the fold changes in the expression of the tested genes using the housekeeping gene 16S rRNA as an endogenous control [51]. The used primers are listed in Table S1. The relative levels of target gene expression were quantified using the 2−ΔΔCt method (the expression levels of isolates before treatment were set to be 1) [56]. Only genes with ≥two-fold changes (either increased or decreased) were regarded to be statistically significant [57].

Membrane Depolarization Assay

This assay was performed after staining the bacterial cells (before and after treatment with DEEL using DiBAC4(3), a fluorescent molecular probe) as previously described [58]. The utilized instrument to analyze the cellular staining was the FACSVerse flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA).

Examination of Morphology by SEM

The cell morphology of MRSA isolates was examined by SEM (Hitachi, Chiyoda, Japan) before and after treatment with DEEL as described by McDowell and Trump [59].

4.4.3. In Vivo Antibacterial Activity Testing

In this experiment, forty adult male albino rats weighing between 180 and 220 g were used. Animals were obtained from the animal house at Menoufia University’s Faculty of Medicine and were acclimatized under laboratory settings for one week before the experiment began. Rats were housed in a safe standard habitat at room temperature, with an unrestricted meal and water supply. Four groups, each with ten animals, were constructed. After removing the dorsal hair and sterilizing with 10% povidone-iodine, a full-thickness excision wound measuring 1.5 × 1.5 cm was created on the mid-back of each animal.
  • Group I (control group): wounds were treated daily with 20% DMSO in normal saline (0.9% (w/v) NaCl freshly prepared).
  • Group II (C. macrocarpa group): wounds were treated daily with a thin layer of DEEL in 20% DMSO in normal saline (1 mg/mL, 1 mm thickness).
  • Group III (MRSA-infected group): MRSA was used to contaminate the wounds with 10 μL of the bacterial suspension (106 CFU).
  • Group VI (MRSA+ C. macrocarpa treated group): wounds were infected with MRSA and treated daily with a thin coating of DEEL in 20% DMSO in normal saline (1 mg/mL, 1 mm thickness).

Histological Study

On day 7, five rats from each group were sacrificed, and the remaining animals were slaughtered on day 14. The skin wound tissues were immediately extracted and handled in 10% formal saline for histological examinations. Tissues fixed in paraffin were sliced into 5 μm thick sections and submitted to Haematoxylin and Eosin (H&E) stain and Mallory’s trichrome stain for collagen fibers procedures [60].

Morphometric Analysis

Ten different isolated fields from each segment were measured for quantitative evaluation using a Leica DML B2/11888111 microscope equipped with a Leica DFC450 camera (Leica Microsystems, Wetzlar, Germany). Image J software version K1.45 was used to estimate the measured variance. H&E and Mallory’s trichrome were used to collect data.
  • Wound closure % = (initial wound size−wound at the time of taking the image)/initial wound size) × 100 [61] mean area percentage of collagen fibers with sections stained with Mallory’s Trichrome (×200).

4.5. Chemical Reagents and Cell Line

Methanol, formic acid, and sodium hydroxide for PH adjustment (Fisher Scientific, Loughborough, UK); vancomycin, acetonitrile, and ammonium formate (Sigma-Aldrich, Darmstadt, Germany); water (Milli-Q) (Millipore, Burlington, VT, USA). Sigma Aldrich provided sulfoxide (DMSO), doxorubicin, Sulfo-Rhod-amine-B stain (SRB) (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), and all the analytical grade solvents used in this study. HSF cell line was obtained from Nawah Scientific Inc. (Mokatam, Cairo, Egypt).

4.6. Cytotoxicity Assay

Cell viability was assessed by SRB assay. In 96-well plates, aliquots of 100 μL cell suspension (5 × 103 cells) were incubated in a complete medium for 24 h. Another aliquot of 100 μL media containing the extract at various concentrations was used to treat the cells. After 72 hrs of exposure to the extract, the cells were fixed by replacing the medium with 150 μL of 10% trichloroacetic acid (TCA) and incubating for one hour at 4 °C. After removing the TCA solution, the cells were washed five times with distilled water. Aliquots of 70 μL of SRB solution (0.4 percent w/v) were added and incubated at room temperature for 10 min in the dark. Plates were washed three times with 1% acetic acid and air-dried overnight. The absorbance was measured at 540 nm using a BMG LABTECH®- FLUOstar Omega microplate reader (BMG LABTECH, Ortenberg, Germany) after 150 μL of TRIS (10 mM) was added to dissolve protein-bound SRB stain [24].

4.7. Statistical Analysis

All the conducted tests were carried out in triplicate. Data are presented as means ± standard deviation (SD) using SPSS software version 26 (IBM Corp., New York, NY, USA). The varied parameters acquired from separate groups were compared using t-test (ANOVA) and Bonferroni’s post hoc test to establish statistical significance. p < 0.001 was used to determine the statistical significance of the data.

5. Conclusions

The elucidation of 49 different compounds was carried out tentatively for the defatted methanol extract of C. macrocarpa leaves using LC-ESI-MS/MS. Isolation of two flavanones, hesperidin and eriocitrin, was conducted for the first time. DEEL demonstrated the best antibacterial activity against 48.78% of MRSA clinical isolates. It significantly reduced the efflux activity by 29.26% as well as downregulating the expression of norA and norB genes in 66.66% and 50% of the clinical isolates, respectively, and significantly affected the bacterial cell morphology. The in vivo study results exhibited that topical treatment with DEEL is highly efficient against cutaneous wound infections in a rat model., which significantly improved wound healing through regenerating the epidermis, maturing granulation tissue, and reducing inflammatory cell infiltration, in comparison with the MRSA-infected group. The in vivo study on rats showed no adverse reactions in all rates during the 14 days. Generally, from the obtained results, we can conclude that DEEL may provide a promising source to develop a curative antibacterial drug against the problematic MRSA bacteria.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/antibiotics10080890/s1, Figure S1: total ion chromatogram (TIC) of methanol extract of C. macrocarpa leaves (negative mode). Figure S2 (a,b,c,d): structure of flavonoids and their glycosides identified in C. macrocarpa leaves and methanol extract of leaves. Figure S3: compounds tentatively identified of C. macrocarpa leaves by LC-ESI-MS/MS (Glu = glucose). Table S1: The sequences of utilized primers.

Author Contributions

Conceptualization, N.G.M.A.; formal analysis, W.A.N., E.E., H.E.-H., and S.A.E.-S.; funding acquisition, N.G.M.A., E.I.E., and T.A.E.-M.; investigation, E.I.E.; methodology, W.A.N., E.E., H.E.-H., and S.A.E.-S.; project administration, N.A.; resources, N.A.; software, N.A.; supervision, T.A.E.-M.; validation, E.I.E.; visualization, N.G.M.A.; writing—original draft, W.A.N., E.E., H.E.-H., and S.A.E.-S.; writing—review & editing, W.A.N., E.E., H.E.-H., S.A.E.-S., and T.A.E.-M. All authors have read and agreed to the published version of the manuscript.

Funding

This work was funded by the Deanship of Scientific Research (DSR) at Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia through the Research Groups Program grant No. (RGP-1441-0028).

Institutional Review Board Statement

The study was conducted according to the guidelines of the Institutional Animal Care and Use Committee (IACUC) at Faculty of Science, Menoufia University. The protocol code was (MUFM-F-HI-1-21) and the approval date was 4 February 2021. The animal should not be overcome by a non-justified burden. Animals should be restrained and transported humanly. Taking care of the animal during the peri-operative time with no negligence was done without mutilation of the animal. The animal was not euthanatized unless required, with balanced ecosystem care for the animal’s husbandry. Care for the infectious, enzootic, epizootic, and zoonotic diseases and informing for the serious diseases was provided. Disposal of animal’s bodies should be in a proper manner.

Data Availability Statement

The data presented in this study are available on request.

Acknowledgments

This work was funded by the Deanship of Scientific Research (DSR) at Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia through the Research Groups Program grant no. (RGP-1441-0028). The authors, therefore, gratefully acknowledge the DSR technical and financial support.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Little, D.P. Evolution and circumscription of the true cypresses (Cupressaceae: Cupressus). Syst. Bot. 2006, 31, 461–480. [Google Scholar] [CrossRef]
  2. Cupressus macrocarpa|International Plant Names Index. Available online: https://www.ipni.org/n/60451557-2 (accessed on 6 May 2021).
  3. Cupressus macrocarpa (Monterey cypress) Description. Available online: https://www.conifers.org/cu/Cupressus_macrocarpa.php (accessed on 6 May 2021).
  4. Thukral, S.K.; Singh, S.; Sharma, S.K. Pharmacognostical standardization of leaves of Cupressus macrocarpa Hartweg. ex Gordon. J. Appl. Pharm. Sci. 2014, 4, 71–74. [Google Scholar] [CrossRef]
  5. Saad, A.M.; Mohammed, M.M.D.; Ghareeb, M.A.; Ahmed, W.S.; Farid, M.A. Chemical Composition and Antimicrobial Activity of the Essential Oil of the Leaves of Cupressus macrocarpa Hartweg. ex Gordon Article Info Abstract. J. Appl. Pharm. Sci. 2017, 7, 207–212. [Google Scholar] [CrossRef] [Green Version]
  6. Salem, M.Z.M.; Elansary, H.O.; Ali, H.M.; El-Settawy, A.A.; Elshikh, M.S.; Abdel-Salam, E.M.; Skalicka-Woźniak, K. Bioactivity of essential oils extracted from Cupressus macrocarpa branchlets and Corymbia citriodora leaves grown in Egypt. BMC Complement. Altern. Med. 2018, 18, 23. [Google Scholar] [CrossRef]
  7. Cool, L.G. Sesquiterpenes from Cupressus macrocarpa foliage. Phytochemistry 2005, 66, 249–260. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Al-Sayed, E.; Ke, T.Y.; Hwang, T.L.; Chen, S.R.; Korinek, M.; Chen, S.L.; Cheng, Y. Bin Cytotoxic and anti-inflammatory effects of lignans and diterpenes from Cupressus macrocarpa. Bioorg. Med. Chem. Lett. 2020, 30, 127127. [Google Scholar] [CrossRef] [PubMed]
  9. Al-Sayed, E.; Gad, H.A.; El-Shazly, M.; Abdel-Daim, M.M.; Nasser Singab, A. Anti-inflammatory and analgesic activities of cupressuflavone from Cupressus macrocarpa: Impact on pro-inflammatory mediators. Drug Dev. Res. 2018, 79, 22–28. [Google Scholar] [CrossRef] [PubMed]
  10. Al-Ashmawy, G.M.; El-Sherbeni, S.A. Protective effect of Cupressus macrocarpa and Dioon edule against gentamicin-induced nephrotoxicity in rats. J. Pharm. Pharmacogn. Res. 2020, 8, 434–448. [Google Scholar]
  11. Fahed, L.; Khoury, M.; Stien, D.; Ouaini, N.; Eparvier, V.; El Beyrouthy, M. Essential Oils Composition and Antimicrobial Activity of Six Conifers Harvested in Lebanon. Chem. Biodivers. 2017, 14, e1600235. [Google Scholar] [CrossRef]
  12. Maleki, S.J.; Crespo, J.F.; Cabanillas, B. Anti-inflammatory effects of flavonoids. Food Chem. 2019, 299, 125124. [Google Scholar] [CrossRef]
  13. Lv, D.; Cheng, X.; Tang, L.; Jiang, M. The cardioprotective effect of total flavonoids on myocardial ischemia/reperfusion in rats. Biomed. Pharmacother. 2017, 88, 277–284. [Google Scholar] [CrossRef]
  14. Sak, K. Cytotoxicity of dietary flavonoids on different human cancer types. Pharmacogn. Rev. 2014, 8, 122–146. [Google Scholar] [CrossRef] [Green Version]
  15. Cushnie, T.P.T.; Lamb, A.J. Antimicrobial activity of flavonoids. Int. J. Antimicrob. Agents 2005, 26, 343–356. [Google Scholar] [CrossRef]
  16. Kumar, S.; Pandey, A.K. Chemistry and biological activities of flavonoids: An overview. Sci. World J. 2013, 2013, 162750. [Google Scholar] [CrossRef] [Green Version]
  17. Techniques of Flavonoid Identification (1982 Edition)|Open Library. Available online: https://openlibrary.org/books/OL3790391M/Techniques_of_flavonoid_identification (accessed on 11 May 2021).
  18. Pollitt, E.J.G.; Szkuta, P.T.; Burns, N.; Foster, S.J. Staphylococcus aureus infection dynamics. PLoS Pathog. 2018, 14, e1007112. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Klein, E.Y.; Mojica, N.; Jiang, W.; Cosgrove, S.E.; Septimus, E.; Morgan, D.J.; Laxminarayan, R. Trends in Methicillin-Resistant Staphylococcus aureus Hospitalizations in the United States, 2010–2014. Clin. Infect. Dis. 2017, 65, 1921–1923. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  20. El-Baz, A.M.; Yahya, G.; Mansour, B.; El-Sokkary, M.M.A.; Alshaman, R.; Alattar, A.; El-Ganiny, A.M. The Link between Occurrence of Class I Integron and Acquired Aminoglycoside Resistance in Clinical MRSA Isolates. Antibiotics 2021, 10, 488. [Google Scholar] [CrossRef]
  21. Chassagne, F.; Samarakoon, T.; Porras, G.; Lyles, J.T.; Dettweiler, M.; Marquez, L.; Salam, A.M.; Shabih, S.; Farrokhi, D.R.; Quave, C.L. A Systematic Review of Plants with Antibacterial Activities: A Taxonomic and Phylogenetic Perspective. Front. Pharmacol. 2021, 11, 2069. [Google Scholar] [CrossRef]
  22. Sani, A.A.; Alemika, T.E. Isolation and characterisation of cupressuflavone from the leaves of Lophira lanceolata. Artic. J. Pharm. Bioresour. 2011, 7, 14–18. [Google Scholar] [CrossRef]
  23. Aguiar, G.P.; Crevelin, E.J.; Dias, H.J.; Ambrósio, S.R.; Bastos, J.K.; Heleno, V.C.G.; Vessecchi, R.; Crotti, A.E.M. Electrospray ionization tandem mass spectrometry of labdane-type acid diterpenes. J. Mass Spectrom. 2018, 53, 1086–1096. [Google Scholar] [CrossRef]
  24. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; Mcmahon, J.; Vistica, D.; Warren, J.T.; Bokesch, H.; Kenney, S.; Boyd, M.R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 1990, 82, 1107–1112. [Google Scholar] [CrossRef]
  25. Maltese, F.; Erkelens, C.; Kooy, F.; van der Choi, Y.H.; Verpoorte, R. Identification of natural epimeric flavanone glycosides by NMR spectroscopy. Food Chem. 2009, 116, 575–579. [Google Scholar] [CrossRef]
  26. Jadeja, Y.S.; Kapadiya, K.M.; Jebaliya, H.J.; Shah, A.K.; Khunt, R.C. Dihedral angle study in Hesperidin using NMR Spectroscopy. Magn. Reson. Chem. 2017, 55, 589–594. [Google Scholar] [CrossRef]
  27. Miyake, Y.; Yamamoto, K.; Osawa, T. Isolation of Eriocitrin(Eriodictyol 7-Rutinoside) from Lemon Fruit(Citrus limon Burm. f.) and Its Antioxidative Activity. Food Sci. Technol. Int. Tokyo 1997, 3, 84–89. [Google Scholar] [CrossRef] [Green Version]
  28. Nogata, Y.; Ohta, H.; Ishii, T.; Sekiya, K. Isolation of eriocitrin (eriodictyol 7-O-rutinoside) as an arachidonate lipoxygenase inhibitor from Lumie fruit (Citrus lumia) and its distribution in Citrus species. J. Sci. Food Agric. 2007, 87, 82–89. [Google Scholar] [CrossRef]
  29. Aslam, B.; Wang, W.; Arshad, M.I.; Khurshid, M.; Muzammil, S.; Rasool, M.H.; Nisar, M.A.; Alvi, R.F.; Aslam, M.A.; Qamar, M.U.; et al. Antibiotic resistance: A rundown of a global crisis. Infect. Drug Resist. 2018, 11, 1645–1658. [Google Scholar] [CrossRef] [Green Version]
  30. Neto, Í.; Faustino, C.; Rijo, P. Antimicrobial abietane diterpenoids against resistant bacteria and biofilms. In The Battle against Microbial Pathogens: Basic Science, Technological Advances and Educational Programs; Méndez-Vilas, A., Ed.; Formatex Research Center: Badajoz, Spain, 2015. [Google Scholar]
  31. Muhammad, I.; Mossa, J.S.; El-Feraly, F.S. Antibacterial diterpenes from the leaves and seeds of Juniperus excelsa M. Bieb. Phyther. Res. 1992, 6, 261–264. [Google Scholar] [CrossRef]
  32. Giweli, A.; Džamic, A.M.; Sokovic, M.; Ristic, M.S.; Marin, P.D. Antimicrobial and antioxidant activities of essential oils of satureja thymbra growing wild in libya. Molecules 2012, 17, 4836. [Google Scholar] [CrossRef] [Green Version]
  33. Zhang, J.; Sun, H.; Chen, S.; Zeng, L.; Wang, T. Anti-fungal activity, mechanism studies on α-Phellandrene and Nonanal against Penicillium cyclopium. Bot. Stud. 2017, 58. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Li, L.; Shi, C.; Yin, Z.; Jia, R.; Peng, L.; Kang, S.; Li, Z. Antibacterial activity of α-terpineol may induce morphostructural alterations in Escherichia coli. Braz. J. Microbiol. 2014, 45, 1409–1413. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Han, Y.; Sun, Z.; Chen, W. Antimicrobial susceptibility and antibacterial mechanism of limonene against Listeria monocytogenes. Molecules 2020, 25, 33. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Foerster, S.; Unemo, M.; Hathaway, L.J.; Low, N.; Althaus, C.L. Time-kill curve analysis and pharmacodynamic modelling for in vitro evaluation of antimicrobials against Neisseria gonorrhoeae. BMC Microbiol. 2016, 16, 216. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Adnan, M.; Patel, M.; Deshpande, S.; Alreshidi, M.; Siddiqui, A.J.; Reddy, M.N.; Emira, N.; De Feo, V. Effect of Adiantum philippense Extract on Biofilm Formation, Adhesion with Its Antibacterial Activities Against Foodborne Pathogens, and Characterization of Bioactive Metabolites: An In Vitro–In Silico Approach. Front. Microbiol. 2020, 11, 823. [Google Scholar] [CrossRef] [PubMed]
  38. Brown, A.R.; Ettefagh, K.A.; Todd, D.A.; Cole, P.S.; Egan, J.M.; Foil, D.H.; Lacey, E.P.; Cech, N.B. Bacterial efflux inhibitors are widely distributed in land plants. J. Ethnopharmacol. 2021, 267, 113533. [Google Scholar] [CrossRef] [PubMed]
  39. Costa, S.S.; Junqueira, E.; Palma, C.; Viveiros, M.; Melo-Cristino, J.; Amaral, L.; Couto, I. Resistance to antimicrobials mediated by efflux pumps in Staphylococcus aureus. Antibiotics 2013, 2, 83. [Google Scholar] [CrossRef] [Green Version]
  40. Tariq, A.; Sana, M.; Shaheen, A.; Ismat, F.; Mahboob, S.; Rauf, W.; Mirza, O.; Iqbal, M.; Rahman, M. Restraining the multidrug efflux transporter STY4874 of Salmonella Typhi by reserpine and plant extracts. Lett. Appl. Microbiol. 2019, 69, 161–167. [Google Scholar] [CrossRef]
  41. Hemaiswarya, S.; Kruthiventi, A.K.; Doble, M. Synergism between natural products and antibiotics against infectious diseases. Phytomedicine 2008, 15, 639–652. [Google Scholar] [CrossRef]
  42. Simões, M.; Bennett, R.N.; Rosa, E.A.S. Understanding antimicrobial activities of phytochemicals against multidrug resistant bacteria and biofilms. Nat. Prod. Rep. 2009, 26, 746–757. [Google Scholar] [CrossRef]
  43. Te Winkel, J.D.; Gray, D.A.; Seistrup, K.H.; Hamoen, L.W.; Strahl, H. Analysis of antimicrobial-triggered membrane depolarization using voltage sensitive dyes. Front. Cell Dev. Biol. 2016, 4, 29. [Google Scholar] [CrossRef] [Green Version]
  44. Famuyide, I.M.; Fasina, F.O.; Eloff, J.N.; McGaw, L.J. The ultrastructural damage caused by Eugenia zeyheri and Syzygium legatii acetone leaf extracts on pathogenic Escherichia coli. BMC Vet. Res. 2020, 16, 1–9. [Google Scholar] [CrossRef]
  45. Wang, C.C.; Yang, P.W.; Yang, S.F.; Hsieh, K.P.; Tseng, S.P.; Lin, Y.C. Topical simvastatin promotes healing of Staphylococcus aureus-contaminated cutaneous wounds. Int. Wound J. 2016, 13, 1150–1157. [Google Scholar] [CrossRef]
  46. Amniattalab, A.; Mohammadi, R. Evaluation of antibiotic activity of methicillin in healing of fullthickness infected wounds with sensitized methicillin resistant Staphylococcus aureus in presence of HAMLET. Iran. J. Basic Med. Sci. 2018, 21, 1043–1049. [Google Scholar] [CrossRef]
  47. Gupta, A.; Kumar, P. Assessment of the histological state of the healing wound. Plast. Aesthetic Res. 2015, 2, 239. [Google Scholar] [CrossRef] [Green Version]
  48. Roy, S.; Santra, S.; Das, A.; Dixith, S.; Sinha, M.; Ghatak, S.; Ghosh, N.; Banerjee, P.; Khanna, S.; Mathew-Steiner, S.; et al. Staphylococcus aureus biofilm infection compromises wound healing by causing deficiencies in granulation tissue collagen. Ann. Surg. 2020, 271, 1174–1185. [Google Scholar] [CrossRef] [PubMed]
  49. Tsugawa, H.; Cajka, T.; Kind, T.; Ma, Y.; Higgins, B.; Ikeda, K.; Kanazawa, M.; Vandergheynst, J.; Fiehn, O.; Arita, M. MS-DIAL: Data-independent MS/MS deconvolution for comprehensive metabolome analysis. Nat. Methods 2015, 12, 523–526. [Google Scholar] [CrossRef]
  50. Weinstein, M.P.; Patel, J.B.; Bobenchik, A.M.; Campeau, S.; Cullen, S.K.; Galas, M.F.; Gold, H.; Humphries, R.M.; Kirn, T.J.; Lewis Ii, J.S.; et al. M100 Performance Standards for Antimicrobial Susceptibility Testing A CLSI Supplement for Global Application. Performance Standards for Antimicrobial Susceptibility Testing Performance Standards for Antimicrobial Susceptibility Testing; Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2020; ISBN 9781684400324. [Google Scholar]
  51. Abd El-Hamid, M.I.; El-Naenaeey, E.S.Y.; Kandeel, T.M.; Hegazy, W.A.H.; Mosbah, R.A.; Nassar, M.S.; Bakhrebah, M.A.; Abdulaal, W.H.; Alhakamy, N.A.; Bendary, M.M. Promising antibiofilm agents: Recent breakthrough against biofilm producing methicillin-resistant Staphylococcus aureus. Antibiotics 2020, 9, 667. [Google Scholar] [CrossRef]
  52. Antibacterial Activity and Phytochemical Analysis of Cardanthera difformis Druce Leaf Extracts from West Bengal, India. Available online: https://www.researchgate.net/publication/287619737_Antibacterial_activity_and_phytochemical_analysis_of_Cardanthera_difformis_druce_leaf_extracts_from_West_Bengal_India (accessed on 18 May 2021).
  53. El-Banna, T.; El-Aziz, A.; Sonbol, F.; El-Ekhnawy, E. Adaptation of Pseudomonas aeruginosa clinical isolates to benzalkonium chloride retards its growth and enhances biofilm production. J. Agric. Food Chem. 2019, 46, 3437–3443. [Google Scholar] [CrossRef] [PubMed]
  54. Sonbol, F.I.; El-Banna, T.E.; Abd El-Aziz, A.A.; El-Ekhnawy, E. Impact of triclosan adaptation on membrane properties, efflux and antimicrobial resistance of Escherichia coli clinical isolates. J. Appl. Microbiol. 2019, 126, 730–739. [Google Scholar] [CrossRef]
  55. Kwak, Y.G.; Truong-Bolduc, Q.C.; Kim, H.B.; Song, K.H.; Kim, E.S.; Hooper, D.C. Association of norb overexpression and fluoroquinolone resistance in clinical isolates of Staphylococcus aureus from Korea. J. Antimicrob. Chemother. 2013, 68, 2766–2772. [Google Scholar] [CrossRef] [Green Version]
  56. Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 2001, 25, 402–408. [Google Scholar] [CrossRef]
  57. Zheng, J.; Tian, F.; Cui, S.; Song, J.; Zhao, S.; Brown, E.W.; Meng, J. Differential gene expression by ramA in ciprofloxacin-resistant Salmonella Typhimurium. PLoS ONE 2011, 6, 22161. [Google Scholar] [CrossRef]
  58. Elekhnawy, E.; Sonbol, F.; Abdelaziz, A.; Elbanna, T. An investigation of the impact of triclosan adaptation on Proteus mirabilis/clinical isolates from an Egyptian university hospital. Braz. J. Microbiol. 2021, 52, 927–937. [Google Scholar] [CrossRef] [PubMed]
  59. McDowell, E.M.; Trump, B.F. Histologic fixatives suitable for diagnostic light and electron microscopy—PubMed. Arch. Pathol. Lab. Med. 1976, 100, 405–414. [Google Scholar] [PubMed]
  60. Suvarna, K.; Layton, C.; Bancroft, J. Bancroft’s Theory and Practice of Histological Techniques—7th Edition, 7th ed.; Churchill Livingstone of Elsevier: Philadelphia, PA, USA, 2013. [Google Scholar]
  61. Adibhesami, M.; Ahmadi, M.; Farshid, A.A.; Sarrafzadeh-Rezaei, F.; Dalir-Naghadeh, B. Effects of silver nanoparticles on Staphylococcus aureus contaminated open wounds healing in mice: An experimental study—PubMed. Vet Res Forum. 2017, 8, 23–28. [Google Scholar] [PubMed]
Antibiotics 10 00890 g001 550
Figure 1. Isolated compounds from C. macrocarpa leaves.
Figure 1. Isolated compounds from C. macrocarpa leaves.
Antibiotics 10 00890 g001
Antibiotics 10 00890 g002 550
Figure 2. The growth curve of representative MRSA isolates showing a significant reduction in growth after treatment with DEEL.
Figure 2. The growth curve of representative MRSA isolates showing a significant reduction in growth after treatment with DEEL.
Antibiotics 10 00890 g002
Antibiotics 10 00890 g003 550
Figure 3. The charts show the fold changes in the transcriptional levels of (a) norA and (b) norB genes after treatment with the diethyl ether extract of C. macrocarpa leaves.
Figure 3. The charts show the fold changes in the transcriptional levels of (a) norA and (b) norB genes after treatment with the diethyl ether extract of C. macrocarpa leaves.
Antibiotics 10 00890 g003
Antibiotics 10 00890 g004 550
Figure 4. A representative example for MRSA isolates showing nonsignificant change in membrane depolarization detected by flow cytometer. Dot plot (a) and histogram (b) before treatment (showing a fluorescent gap of 52.6%), dot plot (c) and histogram (d) after treatment (showing a fluorescent gap of 51.3%).
Figure 4. A representative example for MRSA isolates showing nonsignificant change in membrane depolarization detected by flow cytometer. Dot plot (a) and histogram (b) before treatment (showing a fluorescent gap of 52.6%), dot plot (c) and histogram (d) after treatment (showing a fluorescent gap of 51.3%).
Antibiotics 10 00890 g004
Antibiotics 10 00890 g005 550
Figure 5. Scanning electron microscope image of a representative MRSA isolate (a) before treatment and (b) after treatment with the diethyl ether extract of C. macrocarpa leaves.
Figure 5. Scanning electron microscope image of a representative MRSA isolate (a) before treatment and (b) after treatment with the diethyl ether extract of C. macrocarpa leaves.
Antibiotics 10 00890 g005
Antibiotics 10 00890 g006 550
Figure 6. Illustration of an analysis of wounds that were either untreated or treated with DEEL, MRSA, or MRSA + DEEL. Percentage of wound area contraction (wound contraction%) obtained on days 7 and 14. GI: wounded rats treated with normal saline; GII: wounded rats treated with DEEL; GIII: wounded rats infected with MRSA; GIV: wounded rats infected with MRSA and treated with DEEL of C. macrocarpa. Symbols * and # indicate that the group is significant in comparison to the control group (GI) at p ≤ 0.001 after 7 and 14 days, respectively.
Figure 6. Illustration of an analysis of wounds that were either untreated or treated with DEEL, MRSA, or MRSA + DEEL. Percentage of wound area contraction (wound contraction%) obtained on days 7 and 14. GI: wounded rats treated with normal saline; GII: wounded rats treated with DEEL; GIII: wounded rats infected with MRSA; GIV: wounded rats infected with MRSA and treated with DEEL of C. macrocarpa. Symbols * and # indicate that the group is significant in comparison to the control group (GI) at p ≤ 0.001 after 7 and 14 days, respectively.
Antibiotics 10 00890 g006
Antibiotics 10 00890 g007 550
Figure 7. Sections were taken from a skin wound on day 7. (a) An untreated wound demonstrated epidermal loss (arrow), as well as dermal and epidermal separation (star). Inflammatory cells (arrowhead) are apparent, as are several fibroblast cells (circle), as well as congested blood vessels (BV) and regular collagen fibers (C). (b) A wound treated with DEEL showed epidermal loss (arrow), epidermal layer regeneration (E) with inflammatory cells (arrowhead), collagen fibers (C), and several fibroblast cells (circle). (c) An MRSA-infected wound displayed extensive inflammatory cells (arrowhead) as well as necrotic tissue (star). (d) MRSA-infected wound + DEEL treatment showed wound re-epithelialization (E) with significant inflammatory cells (arrowhead), aggregation, and fibroblast proliferation (circle) (H&E X200).
Figure 7. Sections were taken from a skin wound on day 7. (a) An untreated wound demonstrated epidermal loss (arrow), as well as dermal and epidermal separation (star). Inflammatory cells (arrowhead) are apparent, as are several fibroblast cells (circle), as well as congested blood vessels (BV) and regular collagen fibers (C). (b) A wound treated with DEEL showed epidermal loss (arrow), epidermal layer regeneration (E) with inflammatory cells (arrowhead), collagen fibers (C), and several fibroblast cells (circle). (c) An MRSA-infected wound displayed extensive inflammatory cells (arrowhead) as well as necrotic tissue (star). (d) MRSA-infected wound + DEEL treatment showed wound re-epithelialization (E) with significant inflammatory cells (arrowhead), aggregation, and fibroblast proliferation (circle) (H&E X200).
Antibiotics 10 00890 g007
Antibiotics 10 00890 g008 550
Figure 8. Sections were taken from a skin wound on day 14 (a) An untreated wound indicating aggregation of inflammatory cells (arrowhead), collagen fibers (C) that are regular, partial re-epithelialization (E), and blood capillaries (BV). (b) DEEL-treated wound with newly formed capillaries, increased fibroblast proliferation, dense regular collagen fibers, and re-epithelialization. (c) An MRSA-infected wound displaying poor granulation, numerous inflammatory cells, few fibers, and little re-epithelialization. (d) The wound infected with MRSA and treated with DEEL had an incomplete thin regenerated epidermis and collagen fibers (H&E X200).
Figure 8. Sections were taken from a skin wound on day 14 (a) An untreated wound indicating aggregation of inflammatory cells (arrowhead), collagen fibers (C) that are regular, partial re-epithelialization (E), and blood capillaries (BV). (b) DEEL-treated wound with newly formed capillaries, increased fibroblast proliferation, dense regular collagen fibers, and re-epithelialization. (c) An MRSA-infected wound displaying poor granulation, numerous inflammatory cells, few fibers, and little re-epithelialization. (d) The wound infected with MRSA and treated with DEEL had an incomplete thin regenerated epidermis and collagen fibers (H&E X200).
Antibiotics 10 00890 g008
Antibiotics 10 00890 g009 550
Figure 9. Sections were taken from a skin wound on day 7. (a) Untreated wound exhibited thin collagen fibers (arrow) aligned in different orientations. (b) DEEL-treated wound showed moderate collagen fibers (arrow). (c) An MRSA-infected lesion revealed immature irregular collagen fibers. (d) MRSA-infected lesion with DEEL treatment showed moderate irregular collagen fibers (arrow) (Mallory trichromeX200).
Figure 9. Sections were taken from a skin wound on day 7. (a) Untreated wound exhibited thin collagen fibers (arrow) aligned in different orientations. (b) DEEL-treated wound showed moderate collagen fibers (arrow). (c) An MRSA-infected lesion revealed immature irregular collagen fibers. (d) MRSA-infected lesion with DEEL treatment showed moderate irregular collagen fibers (arrow) (Mallory trichromeX200).
Antibiotics 10 00890 g009
Antibiotics 10 00890 g010 550
Figure 10. Sections obtained from skin wound on day 14. (a) Untreated wound revealed regular moderate collagen fibers. (b) DEEL-treated wound exhibited thick regular collagen fibers. (c) MRSA-infected wound showed scattering irregular collagen fibers (d) MRSA-infected + DEEL treated wound showed immature irregular collagen fibers (Mallory trichromeX200).
Figure 10. Sections obtained from skin wound on day 14. (a) Untreated wound revealed regular moderate collagen fibers. (b) DEEL-treated wound exhibited thick regular collagen fibers. (c) MRSA-infected wound showed scattering irregular collagen fibers (d) MRSA-infected + DEEL treated wound showed immature irregular collagen fibers (Mallory trichromeX200).
Antibiotics 10 00890 g010
Antibiotics 10 00890 g011 550
Figure 11. Illustration of an analysis of area % of collagen that was either untreated or treated with DEEL, MRSA, or MRSA + DEEL. Percentage of collagen (area %) obtained on days 7 and 14. GI: wounded rats treated with normal saline; GII: wounded rats treated with DEEL; GIII: wounded rats infected with MRSA; GIV: wounded rats infected with MRSA and treated with DEEL. Symbols * and # indicate that the group is significant in comparison to the control group (GI) at p ≤ 0.001 after 7 and 14 days, respectively.
Figure 11. Illustration of an analysis of area % of collagen that was either untreated or treated with DEEL, MRSA, or MRSA + DEEL. Percentage of collagen (area %) obtained on days 7 and 14. GI: wounded rats treated with normal saline; GII: wounded rats treated with DEEL; GIII: wounded rats infected with MRSA; GIV: wounded rats infected with MRSA and treated with DEEL. Symbols * and # indicate that the group is significant in comparison to the control group (GI) at p ≤ 0.001 after 7 and 14 days, respectively.
Antibiotics 10 00890 g011
Table
Table 1. Phytochemical profiling of C. macrocarpa leaves extract by LC-ESI-MS/MS in negative mode.
Table 1. Phytochemical profiling of C. macrocarpa leaves extract by LC-ESI-MS/MS in negative mode.
No.Rt (min.)[M − H]−
m/z		MS2
m/z		FormulaIdentification
11.17115.000115.081, 71.017C4H4O4Maleic acid
21.19625.063625.071, 429.022, 369.071, 346.077, 301.012C27H30O17Quercetin-3,4′-O-β-diglucopyranoside
31.21173.046173.044, 155.060, 140.924, 118.587, 109.024, 93.033C7H10O5(-)-Shikimic acid
41.22191.056191.054, 173.046, 133.013, 111.044, 109.024, 93.032C7H12O6D-(-)-Quinic acid
51.23317.053317.055, 281.093, 279.106, 249.00, 191.056C15H10O8Myricetin
61.59163.038163.039, 119.049, 91.014C9H8O33-(4-hydroxyphenyl)prop-2-enoic acid (p-coumaric acid)
74.10577.172577.156, 532.902, 269.104C27H30O14Rhoifolin
83.45447.188447.180, 401.180, 301.151, 239.127, 179.070, 151.046, 119.035C21H20O11Quercitrin
94.60417.139417.134, 371.169, 285.92, 209.0788C20H18O10Kaempferol-3-O-alpha-L-arabinoside
104.66461.148461.127, 392.912, 285.103C21H18O12Kaempferol-3-O-Glucuronide
114.80283.096283.090, 179.100, 171.098, 146.956, 73.030C16H12O5Acacetin
124.84289.070289.067, 245.084, 205.044, 187.040, 179.046, 151.044, 123.052C15H14O6Catechin
135.10183.025183.034C8H8O53,4-Dihydroxymandelate
145.65431.191431.192, 383.924, 285.213, 165.095, 159.034, 149.047, 125.023, 119.035C21H20O10Kaempferol-3-O-alpha-L-rhamnoside
155.67385.172385.184, 248.947, 223.131, 205.121, 190.970, 179.053, 161.042, 149.052, 119.035, 71.016C17H22O101-O-β-D-glucopyranosyl sinapate
165.89463.169463.171, 403.151, 317.103, 301.093, 208.087, 194.033, 150.056C21H20O12Myricitrin
176.01449.108449.102, 403.165, 381.167, 287.03293, 269.042, 179.002, 151.00, 107.022C21H22O11Eriodictyol-7-O-glucoside
186.260609.143609.146, 563.234, 496.863, 285.201, 315.043 300.03C27H30O16Luteolin-3′, 7-di-O-glucoside
196.29433.111433.115, 271.053, 151.036, 119.043C21H22O10Naringenin-7-O-glucoside
206.69435.092435.084, 417.083, 389.214, 309.053, 285.040, 178.993, 151.042, 125.023C21H24O10Phlorizin
216.79449.102449.114, 431.080, 342.910, 303.049, 285.045, 276.910, 151.00C21H22O11Okanin-4′-O-glucoside
226.97595.169595.286, 548.851, 480.844, 315.058, 287.030C27H32O15Eriodictyol-7-O-rutinoside
236.99445.171445.169, 269.142, 112.989C21H18O11Baicalein-7-O-glucuronide
246.98623.063623.208, 579.156, 532.918, 315.036C28H32O16Isorhamnetin-3-O-rutinoside
257.15609.521609.144, 301.027C28H34O15Hesperidin
267.24433.076433.077, 389.175, 385.201, 326.928, 301.037, 300.030, 287.049, 271.025C20H18O11Quercetin-3-O-Arabinoside
277.48477.099477.098, 431.222, 364.927, 331.042, 315.041, 300.043C22H22O12Isorhamnetin-3-O-glucoside
287.52507.111507.102, 489.186, 461.112, 345.057, 326.930, 315.061, 286.951, 269.121C23H24O13Syringetin-3-O-glucoside
297.53447.092447.088, 401.248, 301.034, 300.020, 285.040, 271.026C21H20O11Quercetin-7-O-rhamnoside
307.57433.079433.080, 349.103, 326.928, 301.036, 300.023, 269.047, 178.993, 152.010C20H18O11Quercetin-3-D-xyloside
317.67405.061405.093, 369.248, 231.0, 209.066, 191.056, 137.020C20H22O9E-3,4,5′-Trihydroxy-3′-glucopyranosyl-stilbene
327.70463.088463.119, 394.907, 354.924, 331.054, 316.021, 301.066, 286.934C21H20O12Quercetin-4′-glucoside
337.87431.097431.092, 385.175, 341.181, 299.023, 269.035C21H20O10Apigenin-7-O-glucoside
347.90447.182447.096, 401.202, 285.040, 112.989C21H20O11Luteolin-7-O-glucoside
357.82415.197415.195, 369.212, 253.165, 179.063, 161.042, 113.020C21H20O9Daidzein-8-C-glucoside
368.22507.111507.112, 462.907, 445.205, 430.890, 394.919, 371.207, 345.124, 329.041, 286.932C23H24O13Syringetin-3-O-galactoside
378.39301.123301.118C16H14O6Hesperetin
389.57537.083537.021, 518.951, 493.504, 468.105, 255.025, 248.956, 213.018, 197.059C30H18O10Cupressuflavone
399.76301.037301.036, 255.221, 243.039, 178.997, 151.0094C15H10O7Quercetin
4010.08
299.056299.055, 284.042C16H12O63,5,7-Trihydroxy-4′-methoxy-flavone
4110.12359.169359.176C18H16O8Rosmarinic acid
4210.23181.047181.049, 166.031, 138.030, 112.986C9H10O4Syringaldehyde
4310.29271.060271.064, 177.022, 151.004, 119.046, 107.020C15H12O5Naringenin
4410.85611.113611.117, 565.214, 504.961C28H36O15Neohesperidin dihydrochalcone
4510.96285.039285.038, 185.068C15H10O6Luteolin
4611.23315.109315.169, 300.028, 297.187, 283.022, 269.246, 246.898, 235.177, 141.018C16H12O73′-Methoxy-4′,5,7-trihydroxyflavonol
4715.14319.227319.226, 318.20, 255.209, 248.572, 164.252C20H32O3Isocupressic acid
4819.60361.238361.237, 319.231, 301.218, 283.165C22H34O4Acetylisocupressic acid
4923.33305.248305.249, 304.280, 166.095C20H34O2Agathadiol
Table
Table 2. Efflux activity of MRSA isolates, measured by EtBr cartwheel method, before and after treatment with DEEL.
Table 2. Efflux activity of MRSA isolates, measured by EtBr cartwheel method, before and after treatment with DEEL.
Efflux ActivityNo. of Isolates before
Treatment		No. of Isolates after Treatment
Negative efflux activity821
Intermediate efflux activity1413
Positive efflux activity197
Table
Table 3. Percentage of wound contraction and area percentage of collagen in different groups.
Table 3. Percentage of wound contraction and area percentage of collagen in different groups.
X− ± SD
GIGIIGIIIGIVp-Value
Wound contraction % (7 days)33.73 ± 1.3238 ± 1.714 ± 2.5830 ± 1.82P1 = 0.0001
P2 = 0.0001
P3 = 0.0001
P4 = 0.0001
Wound contraction % (14 days)67.5 ± 3.0383.9 ± 2.2830.1 ± 4.2861 ± 2.9P1 = 0.0001
P2 = 0.0001
P3 = 0.0001
P4 = 0.0001
Area % of collagen (7 days)39 ± 2.1643.8 ± 1.1325.3 ±2.934.1±1.19P1 = 0.0001
P2 = 0.0001
P3 = 0.0001
P4 = 0.0001
Area % of collagen (14 days)62.1 ±2.5167.9 ±1.3742.4 ±3.8651.4 ±2.59P1 = 0.0001
P2 = 0.0001
P3 = 0.0001
P4 = 0.0001
GI: wounded rats treated with normal saline; GII: wounded rats treated with DEEL; GIII: wounded rats infected with MRSA; GIV = wounded rats infected with MRSA and treated with DEEL; X−: mean value; SD: standard deviation; significance: (p-value ≤ 0.001). P1: group 2 compared to control; P2: group 3 compared to control; P3: group 4 compared to control; P4: group 4 compared to group 3.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Attallah, N.G.M.; Negm, W.A.; Elekhnawy, E.; Elmongy, E.I.; Altwaijry, N.; El-Haroun, H.; El-Masry, T.A.; El-Sherbeni, S.A. Elucidation of Phytochemical Content of Cupressus macrocarpa Leaves: In Vitro and In Vivo Antibacterial Effect against Methicillin-Resistant Staphylococcus aureus Clinical Isolates. Antibiotics 2021, 10, 890. https://doi.org/10.3390/antibiotics10080890

AMA Style

Attallah NGM, Negm WA, Elekhnawy E, Elmongy EI, Altwaijry N, El-Haroun H, El-Masry TA, El-Sherbeni SA. Elucidation of Phytochemical Content of Cupressus macrocarpa Leaves: In Vitro and In Vivo Antibacterial Effect against Methicillin-Resistant Staphylococcus aureus Clinical Isolates. Antibiotics. 2021; 10(8):890. https://doi.org/10.3390/antibiotics10080890

Chicago/Turabian Style

Attallah, Nashwah G. M., Walaa A. Negm, Engy Elekhnawy, Elshaymaa I. Elmongy, Najla Altwaijry, Hala El-Haroun, Thanaa A. El-Masry, and Suzy A. El-Sherbeni. 2021. "Elucidation of Phytochemical Content of Cupressus macrocarpa Leaves: In Vitro and In Vivo Antibacterial Effect against Methicillin-Resistant Staphylococcus aureus Clinical Isolates" Antibiotics 10, no. 8: 890. https://doi.org/10.3390/antibiotics10080890

APA Style

Attallah, N. G. M., Negm, W. A., Elekhnawy, E., Elmongy, E. I., Altwaijry, N., El-Haroun, H., El-Masry, T. A., & El-Sherbeni, S. A. (2021). Elucidation of Phytochemical Content of Cupressus macrocarpa Leaves: In Vitro and In Vivo Antibacterial Effect against Methicillin-Resistant Staphylococcus aureus Clinical Isolates. Antibiotics, 10(8), 890. https://doi.org/10.3390/antibiotics10080890

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop